Associate Professor Mariusz Skwarczynski
Associate Professor

Mariusz Skwarczynski

Email: 
Phone: 
+61 7 334 69894

Background

Mariusz Skwarczynski completed his Ph.D. in Chemistry in 1999 at Wroclaw University of Technology (Poland). His postdoctoral training began at Tokushima Bunri University (Japan), and then Kyoto Pharmaceutical University (Japan). In 2008 he joined Professor Istvan Toth’s group at The University of Queensland (Australia) to work on new vaccine development strategies. Currently his group activity is mainly focused on nanotechnology-based peptide vaccine delivery approaches and adjuvants discovery. He is Regional Editor of Australia in Vaccines, and Associate Editor in Frontiers in Pharmacology. He has published over 190 peer-reviewed publications, including 18 book chapters and three books.

Availability

Associate Professor Mariusz Skwarczynski is:
Available for supervision
Media expert

Fields of research

Medicinal and biomolecular chemistry Organic chemistry

Qualifications

  • Masters (Coursework) of Science, Wroclaw University of Technology
  • Doctor of Philosophy, Wroclaw University of Technology
  • Member, Australian Infectious Diseases Research Centre, Australian Infectious Diseases Research Centre
  • Journal Editorial Board Member, Current Drug Delivery, Current Drug Delivery
  • Journal Editorial Board Member, Frontiers in Pharmacology (Associate Editor), Frontiers in Pharmacology (Associate Editor)
  • Journal Editorial Board Member, Medicinal Chemistry, Medicinal Chemistry
  • Member, Royal Australian Chemical Institute, Royal Australian Chemical Institute
  • Member, The Japan Society for the Promotion of Science Alumni Association in Australia, The Japan Society for the Promotion of Science Alumni Association in Australia
  • Journal Editorial Board Member, Vaccines (Regional Editor of Australia), Vaccines (Regional Editor of Australia)

Research interests

  • Vaccines and Nanomedicine

    Vaccine Design, Adjuvants, Nanotechnology, Peptide Chemistry, Medicinal Chemistry, Vaccine/Drug Delivery, Antimicrobial Agents, Macromolecules, Immunology

Research impacts

Mariusz Skwarczynski work focuses on nanotechnology-based approaches to vaccine adjuvants, with the potential for significant practical applications in developing novel vaccines. He has co-developed unique peptide, polymer, and liposomes-based adjuvanting systems used in vaccine development against malaria, hookworm, Group A Streptococcus, cancer and fertility vaccines.

As per January 2026:

He has published 3 books, 18 book chapters, and over 170 journal papers (~ 40 first and ~ 40 as last author, h index = 55, citations >9000), with a Field-Weighted Citation Impact of 2.14 (twice higher than the average researcher), and 29.9% of publications in last 5-years are in the top 10% of journals by CiteScore. Ranked 5th (Top 0.027% of 18,422) in the world in Subunit Vaccines (2012-2022; ExpertScape) and listed in World’s Top 2% Scientists by Stanford University in 2024, inside the top 0.35% in medicinal & biomolecular chemistry. His publications have received > 150 patent cites.

In the past 10 years, he secured $33.8M in grant funding, including $3.0M as the principle CI, $10.1M as a CI and $20.7M as the AI. He currently holds five grants as a CI: 2xNHMRC Ideas (CIA, 2024-27, $608K; CIA, 2024-27, $856K), CRE NHMRC (CIF, 2026-31, $3,000K), Synergy NHMRC (CIF, 2026-31, $5,000K), and ARC DP (CIA, 2026-30, $1,073K).

He has been invited 21 times in the last 5 years to present at international seminars and conferences,including invited lectures at National Nanotechnology Center (NANOTEC) (Bangkok, Thailand), Istituto Zooprofilattico Sperimentale del Mezzogiorno (Campania, Italy), University of Opole, (Opole, Poland), and 5th International Symposium on Synthetic Peptide as Human and Veterinary Pharmaceutical Products, (Varadero, Cuba). His work has received over 39 news articles from national and international agencies, including 11 interviews and articles in 2021 from Australia, India, Pakistan, Hungary, Kenya and New Zealand for his work on the oral hookworm vaccine.

He is the Regional Editor of Australia for Vaccines and Associate Editor for Frontiers in Pharmacology. He has organised 9 special issues in the last 5 years for journals such as Vaccines, Molecules and Frontiers in Pharmacology. Furthermore, he organised and chaired “Micro and Nanoparticles in Drug and Vaccine Delivery Symposium”, St Lucia, QLD, 3rd December 2021. He regularly reviews domestic grants, for example, 13 NHMRC Ideas grants in 2024, as well as international, for example, Austrian Science Fund, Netherlands Organisation for Scientific Research, The Wellcome Trust, Medical Research Council (UK). Peer reviews >10/year for top international journals (e.g. Nat. Commun.; Adv. Sci.; Adv. Mater.; Adv. Drug Deliv. Rev; Acta Biomater.).

He was/is co/supervisor of 33 PhD students (graduated and ongoing), and co/supervisor of over 30 research students. In the years 2019-2025, his supervised students received eleven awards, including the Dean’s Award for Outstanding Higher Degree by Research Theses, and awards at international conferences (travel, best poster, best oral presentations).

Search Professor Mariusz Skwarczynski’s works on UQ eSpace

212 works between 1995 and 2026
All (212) Book (3) Journal Article (178) Other Outputs (2) Conference Publication (9) Book Chapter (20)

201 - 212 of 212 works

2006

Journal Article

O-N intramolecular alkoxycarbonyl migration of typical protective groups in hydroxyamino acids

Skwarczynski, Mariusz, Sohma, Youhei, Noguchi, Mayo, Kimura, Tooru, Hayashi, Yoshio and Kiso, Yoshiaki (2006). O-N intramolecular alkoxycarbonyl migration of typical protective groups in hydroxyamino acids. Journal of Organic Chemistry, 71 (6), 2542-2545. doi: 10.1021/jo0525579

O-N intramolecular alkoxycarbonyl migration of typical protective groups in hydroxyamino acids

2005

Journal Article

No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: Scope and limitation of O-N intramolecular acyl and acyloxy migration reactions

Skwarczynski, Mariusz, Sohma, Youhei, Noguchi, Mayo, Kimura, Maiko, Hayashi, Yoshio, Hamada, Yoshio, Kimura, Tooru and Kiso, Yoshiaki (2005). No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: Scope and limitation of O-N intramolecular acyl and acyloxy migration reactions. Journal of Medicinal Chemistry, 48 (7), 2655-2666. doi: 10.1021/jm049344g

No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: Scope and limitation of O-N intramolecular acyl and acyloxy migration reactions

2004

Conference Publication

O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides

Sohma, Y, Hayashi, Y, Skwarczynski, M, Hamada, Y, Sasaki, M, Kimura, T and Kiso, Y (2004). O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides. 9th Naples Workshop on Bioactive Peptides, Naples Italy, May 08-11, 2004. MALDEN: WILEY-BLACKWELL. doi: 10.1002/bip.20136

O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides

2003

Journal Article

O-N intramolecular acyl migration strategy in water-soluble prodrugs of taxoids

Skwarczynski, M, Sohma, Y, Kimura, M, Hayashi, Y, Kimura, T and Kiso, Y (2003). O-N intramolecular acyl migration strategy in water-soluble prodrugs of taxoids. Bioorganic & Medicinal Chemistry Letters, 13 (24), 4441-4444. doi: 10.1016/j.bmcl.2003.09.020

O-N intramolecular acyl migration strategy in water-soluble prodrugs of taxoids

2003

Journal Article

A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: Design and synthesis of isotaxel

Hayashi, Y, Skwarczynski, M, Hamada, Y, Sohma, Y, Kimura, T and Kiso, Y (2003). A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: Design and synthesis of isotaxel. Journal of Medicinal Chemistry, 46 (18), 3782-3784. doi: 10.1021/jm034112n

A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: Design and synthesis of isotaxel

2003

Journal Article

Mercuric triflate catalyzed hydroxylative carbocyclization of 1,6-enynes

Nishizawa, M, Yadav, VK, Skwarczynski, M, Takao, H, Imagawa, H and Sugihara, T (2003). Mercuric triflate catalyzed hydroxylative carbocyclization of 1,6-enynes. Organic Letters, 5 (10), 1609-1611. doi: 10.1021/ol034201u

Mercuric triflate catalyzed hydroxylative carbocyclization of 1,6-enynes

2002

Journal Article

Mercuric triflate-TMU catalyzed hydration of terminal alkyne to give methyl ketone under mild conditions

Nishizawa, M, Skwarczynski, M, Imagawa, H and Sugihara, T (2002). Mercuric triflate-TMU catalyzed hydration of terminal alkyne to give methyl ketone under mild conditions. Chemistry Letters, 31 (1), 12-13. doi: 10.1246/cl.2002.12

Mercuric triflate-TMU catalyzed hydration of terminal alkyne to give methyl ketone under mild conditions

1999

Journal Article

Enantioselective hydrolysis of 1-butyryloxyalkylphosphonates by lipolytic microorganisms: Pseudomonas fluorescens and Penicillium citrinum

Skwarczynski, M, Lejczak, B and Kafarski, P (1999). Enantioselective hydrolysis of 1-butyryloxyalkylphosphonates by lipolytic microorganisms: Pseudomonas fluorescens and Penicillium citrinum. Chirality, 11 (2), 109-114. doi: 10.1002/(SICI)1520-636X(1999)11:23.0.CO;2-T

Enantioselective hydrolysis of 1-butyryloxyalkylphosphonates by lipolytic microorganisms: Pseudomonas fluorescens and Penicillium citrinum

1996

Journal Article

Accurate assay of enantiopurity of 1-hydroxy- and 2-hydroxyalkylphosphonate esters

Zymanczykduda, E, Skwarczynski, M, Lejczak, B and Kafarski, P (1996). Accurate assay of enantiopurity of 1-hydroxy- and 2-hydroxyalkylphosphonate esters. Tetrahedron-Asymmetry, 7 (5), 1277-1280. doi: 10.1016/0957-4166(96)00143-7

Accurate assay of enantiopurity of 1-hydroxy- and 2-hydroxyalkylphosphonate esters

1996

Journal Article

The Use of Lypolitic Microorganisms Pseudomonas fluorescens and Penicillium citrinum for the Preparation of Optically Active 1 -Hydroxyalkylphosphonates

Lejczak, Barbara, Haliniarz, Ewa, Skwarczynski, Mariusz and Kafarski, Pawel (1996). The Use of Lypolitic Microorganisms Pseudomonas fluorescens and Penicillium citrinum for the Preparation of Optically Active 1 -Hydroxyalkylphosphonates. Phosphorus, Sulfur, and Silicon and the Related Elements, 111 (1), 86-86. doi: 10.1080/10426509608054715

The Use of Lypolitic Microorganisms Pseudomonas fluorescens and Penicillium citrinum for the Preparation of Optically Active 1 -Hydroxyalkylphosphonates

1996

Conference Publication

The use of lypolitic microorganisms Pseudomonas fluorescens and Penicillium citrinum for the preparation of optically active 1-hydroxyalkylphosphonates

Lejczak, B, Haliniarz, E, Skwarczynski, M and Kafarski, P (1996). The use of lypolitic microorganisms Pseudomonas fluorescens and Penicillium citrinum for the preparation of optically active 1-hydroxyalkylphosphonates. 13th International Conference on Phosphorus Chemistry (XIIITH ICPC), Jerusalem Israel, Jul 16-21, 1995. READING: GORDON BREACH SCI PUBL LTD.

The use of lypolitic microorganisms Pseudomonas fluorescens and Penicillium citrinum for the preparation of optically active 1-hydroxyalkylphosphonates

1995

Journal Article

Alkylation of Potassium 1-(n-Benzyloxycarbonylamino)alkylphosphonates and Phosphinates in the Presence of 18-Crown-6

Skwarczynski, M and Kafarski, P (1995). Alkylation of Potassium 1-(n-Benzyloxycarbonylamino)alkylphosphonates and Phosphinates in the Presence of 18-Crown-6. Synthetic Communications, 25 (22), 3565-3571. doi: 10.1080/00397919508015491

Alkylation of Potassium 1-(n-Benzyloxycarbonylamino)alkylphosphonates and Phosphinates in the Presence of 18-Crown-6

Current funding

  • 2026 - 2030
    Oral anti-fertility vaccine for population control of invasive rabbits
    ARC Discovery Projects
    Open grant
  • 2024 - 2027
    A nanovaccine against Invasive Group A Streptococcus and Rheumatic Heart Disease
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Paving the way for a Clinical Vaccine Candidate against Hookworm Infection
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2024 - 2025
    Single-shot anti-fertility vaccine in pigs
    Australia's Economic Accelerator Seed Grants
    Open grant
  • 2021 - 2024
    Poly(amino acids) as immune stimulators
    ARC Discovery Projects
    Open grant
  • 2021 - 2025
    A single-shot anti-fertility vaccine in female cattle
    Meat & Livestock Australia
    Open grant
  • 2020 - 2021
    Hookworm peptide therapeutic for oral treatment of IBD (NHMRC Development Grant administered by James Cook University)
    James Cook University
    Open grant
  • 2011 - 2014
    A Self-assembling and Self-adjuvanting Nanoparticular Therapeutic Vaccine Against Cervical Cancer
    NHMRC Project Grant
    Open grant

Availability

Associate Professor Mariusz Skwarczynski is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • A nanonaccine against Invasive Group A Streptococcus and Rheumatic Heart Disease

    The major challenge in any vaccine development is its formulation/delivery once the target antigens are identified. The main aim of this project is to adopt and further develop our immune-stimulating delivery systems to produce a multicomponent synthetic (poly)peptide vaccine candidate against Group A Streptococcus (GAS), the major causative agent of deadly diseases such as rheumatic heart disease (RHD) and invasive GAS infection. Notably, a variety of vaccines against GAS infection have reached clinical trials in the past decades; however, these vaccines have limited efficacy due to the high variability of GAS strains. We hypothesise that the incorporation of three conserved peptide antigens from GAS proteins into our newly developed nanoparticles-based vaccine delivery systems will overcome the above obstacles and produce an efficient and universal vaccine candidate against GAS. The project will deliver preclinical vaccine candidates against Group A Streptococcus, which, after oral dosing, will be able to induce robust opsonic antibody production against a wide range of GAS strains without triggering adverse effects and off-target immune responses. We will employ peptide antigens from the highly conserved region of M-protein, cell envelope proteinase, and fibronectin-binding protein 1. The optimized vaccine delivery system will be easily adaptable for the development of vaccines against other diseases.

  • Oral anti-fertility vaccine for rabbits

    Develop the first oral vaccines that suppress fertility in rabbits and enable responsible and ethical landscape population control. Expected outcomes of this project include the creation of a commercially attractive oral immunization platform.

    Who can apply: medicinal/peptide chemists with preferable knowledge in immunology and pharmaceutical formulations.

Supervision history

Current supervision

Completed supervision

Enquiries

Contact Associate Professor Mariusz Skwarczynski directly for media enquiries about:

  • fertility control
  • group A streptococcus
  • hookworm
  • immune adjuvants
  • nanovaccines
  • peptide vaccines

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au